Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy.
about
XL-184, a MET, VEGFR-2 and RET kinase inhibitor for the treatment of thyroid cancer, glioblastoma multiforme and NSCLC.c-Ret-mediated hearing loss in mice with Hirschsprung diseasec-RET molecule in malignant melanoma from oncogenic RET-carrying transgenic mice and human cell linesMedullary thyroid carcinoma: molecular signaling pathways and emerging therapiesNovel targets in non-small cell lung cancer: ROS1 and RET fusionsRET oncogene in MEN2, MEN2B, MTC and other forms of thyroid cancer.High resolution array-comparative genomic hybridization profiling reveals deoxyribonucleic acid copy number alterations associated with medullary thyroid carcinoma.Loss of pigment epithelium-derived factor: a novel mechanism for the development of endocrine resistance in breast cancer.RET TKI: potential role in thyroid cancers.c-Ret-mediated hearing losses.Hearing impairments caused by genetic and environmental factors.Sorafenib and thyroid cancer.Proteomics study of medullary thyroid carcinomas expressing RET germ-line mutations: identification of new signaling elements.Selective use of vandetanib in the treatment of thyroid cancer.Thyroid C-Cell Biology and Oncogenic Transformation.MiR-182 promotes cancer invasion by linking RET oncogene activated NF-κB to loss of the HES1/Notch1 regulatory circuit.GDNF induces RET-SRC-HER2-dependent growth in trastuzumab-sensitive but SRC-independent growth in resistant breast tumor cells.The safety and efficacy of vandetanib in the treatment of progressive medullary thyroid cancer.MiR-129-5p is down-regulated and involved in the growth, apoptosis and migration of medullary thyroid carcinoma cells through targeting RET.High-resolution analysis of alterations in medullary thyroid carcinoma genomes.Growth inhibition of medullary thyroid carcinoma cells by pyrazolo-pyrimidine derivates.Personalization of targeted therapy in advanced thyroid cancer.Cellular signaling pathway alterations and potential targeted therapies for medullary thyroid carcinoma.Evaluation of systemic targeting of RET oncogene-based MTC with tumor-selective peptide-tagged Ad vectors in clinical mouse models.
P2860
Q30428632-4708C616-B174-43D6-BD8F-AAA8A4FE4FF8Q30477530-EAF85B9A-7C48-4203-9D16-FA7C70C40811Q33565577-AA894354-99CE-4A08-BDC2-BF17353AA0FAQ35038893-37A6BB75-81E0-4CFC-88B6-46077456467AQ37038500-9C5E8B54-4D7A-4107-BF87-E5C104C01A0CQ37134454-F081A982-68DE-4751-9A1A-CDAECBB704E9Q37311366-E6DCD7EC-EED5-4C9A-BEA3-B5AA8CFA0C40Q37531200-981FB780-520C-4A35-9F07-9D4B3540D77AQ37979656-7F2EFF88-3F13-4CC4-9250-E4F6CA3D3A7CQ37980452-7D51FA49-76C2-49C6-9980-FD531A95EA31Q38035208-FCB46C84-AF05-4FC4-8D73-4F457D0ADB78Q38118647-2E5A512B-EE2B-4B05-921B-6EAAAF71F748Q38425184-1C996ECD-5844-4BFB-9A14-FCEA189FF2F6Q38546474-911F8FE3-30E8-4D5A-8FAB-308EB2441986Q38614485-CB545E3D-1631-48D2-BB4D-26299623CA83Q38719449-6C4A7DBB-CB65-4125-8A57-1702B851C562Q38719786-FCF30086-77E4-42FC-8207-81185490A953Q38960074-4A7F7969-2CB0-4FD1-8EFE-12A75AEF3A86Q39015324-C1F549DC-C14B-41D2-84D8-5DE80B95ADA9Q39450576-6A1FDED5-BF90-45F5-A67F-552F6B91D681Q40036483-2F1B7CD5-3244-4137-9BAF-76C57AD9363FQ40922523-955B2B08-6CBC-4E9E-8005-D1D5E0B09F3DQ41251561-AFE79BA9-D12D-444F-8B9C-59FE7E0315E6Q45866246-A9F20786-544A-422D-BFE7-AE83F7C34483
P2860
Mechanisms of Disease: cancer targeting and the impact of oncogenic RET for medullary thyroid carcinoma therapy.
description
2006 nî lūn-bûn
@nan
2006年の論文
@ja
2006年論文
@yue
2006年論文
@zh-hant
2006年論文
@zh-hk
2006年論文
@zh-mo
2006年論文
@zh-tw
2006年论文
@wuu
2006年论文
@zh
2006年论文
@zh-cn
name
Mechanisms of Disease: cancer ...... ary thyroid carcinoma therapy.
@ast
Mechanisms of Disease: cancer ...... ary thyroid carcinoma therapy.
@en
type
label
Mechanisms of Disease: cancer ...... ary thyroid carcinoma therapy.
@ast
Mechanisms of Disease: cancer ...... ary thyroid carcinoma therapy.
@en
prefLabel
Mechanisms of Disease: cancer ...... ary thyroid carcinoma therapy.
@ast
Mechanisms of Disease: cancer ...... ary thyroid carcinoma therapy.
@en
P2860
P356
P1476
Mechanisms of Disease: cancer ...... lary thyroid carcinoma therapy
@en
P2093
Brigitte M Pützer
P2860
P304
P356
10.1038/NCPONC0610
P577
2006-10-01T00:00:00Z